Clinical Trial

Myotonic Dystrophy Type 1 Aerobic Exercise

Study Description

Myotonic Dystrophy Type 1 Aerobic Exercise Study

Myotonic dystrophy type 1 (DM1) is a genetic disease that primarily targets skeletal muscle resulting in severe weakness and muscle loss. As a result, individuals suffering from DM1 become very inactive and lose mobility resulting in a lower quality of life. This study will investigate the effect of a 12-week moderate intensity exercise protocol on skeletal muscle function and cellular benefits in DM1 patients.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Exercise training

All participants with DM1 will undergo a 12-week aerobic exercise training intervention on a cycle ergometer

Additional Information

Official Study Title

Functional and Cellular Benefits of Aerobic Exercise in Myotonic Dystrophy Type 1 Patients

Clinical Trial ID

NCT04187482

ParticipAid ID

b68P7e